These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 19106780)
1. Pertussis vaccine effectiveness after mass immunization of high school students in Australia. Rank C; Quinn HE; McIntyre PB Pediatr Infect Dis J; 2009 Feb; 28(2):152-3. PubMed ID: 19106780 [TBL] [Abstract][Full Text] [Related]
2. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787 [TBL] [Abstract][Full Text] [Related]
3. Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine. Terranella A; Rea V; Griffith M; Manning S; Sears S; Farmer A; Martin S; Patel M Vaccine; 2016 May; 34(22):2496-500. PubMed ID: 27038131 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Iskedjian M; Walker JH; Hemels ME Vaccine; 2004 Oct; 22(31-32):4215-27. PubMed ID: 15474711 [TBL] [Abstract][Full Text] [Related]
5. Enhanced surveillance for vaccine-associated adverse events: dTap catch-up of high school students in Yukon. David ST; Hemsley C; Pasquali PE; Larke B; Buxton JA; Lior LY Can Commun Dis Rep; 2005 Jun; 31(11):117-26. PubMed ID: 15940837 [No Abstract] [Full Text] [Related]
6. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control. Kirkland KB; Talbot EA; Decker MD; Edwards KM Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of pertussis and high expectations concerning vaccines]. Wysocki J Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study. Okada K; Ohashi Y; Matsuo F; Uno S; Soh M; Nishima S Epidemiol Infect; 2009 Jan; 137(1):124-30. PubMed ID: 18474125 [TBL] [Abstract][Full Text] [Related]
10. [Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy]. van Wijngaarden JK; Huisman J; van der Meer JW; Visser HK Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2297-301. PubMed ID: 11143295 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395 [TBL] [Abstract][Full Text] [Related]
12. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Dylag AM; Shah SI Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489 [TBL] [Abstract][Full Text] [Related]
14. Tetanus, diphtheria, and acellular pertussis vaccine: a position statement of the Society for Adolescent Medicine. Middleman AB; Bruner A J Adolesc Health; 2009 Sep; 45(3):316-7. PubMed ID: 19699431 [No Abstract] [Full Text] [Related]
15. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States. Mink CM Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991 [No Abstract] [Full Text] [Related]
16. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use. Hitchcock WP Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165 [TBL] [Abstract][Full Text] [Related]
17. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. Gidengil CA; Sandora TJ; Lee GM Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of postvaccinal response in children past pertussis]. Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498 [TBL] [Abstract][Full Text] [Related]
19. Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness. Torm S; Meriste S; Tamm E; Alusalu S; Järviste A; Lang K Scand J Infect Dis; 2005; 37(9):664-8. PubMed ID: 16126567 [TBL] [Abstract][Full Text] [Related]
20. Potential impact of acceleration of the pertussis vaccine primary series for infants. Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]